Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr

What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Operating Activities ratio of NATCO PHARMA is ₹1,697 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹1,697 Cr
Mar2024₹1,212 Cr
Mar2023₹849 Cr
Mar2022₹47 Cr
Mar2021₹299 Cr

How is Cash Flow from Operating Activities of NATCO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹1,697 Cr
40.05
Mar2024 ₹1,212 Cr
42.69
Mar2023 ₹849 Cr
1,726.02
Mar2022 ₹47 Cr
-84.44
Mar2021 ₹299 Cr -

Compare Cash Flow from Operating Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,462.3 Cr 5.1% -0.4% 17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

5.1%

-0.4%

17.9%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses